The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.


Autoria(s): Davey,CG; Chanen,AM; Cotton,SM; Hetrick,SE; Kerr,MJ; Berk,M; Dean,OM; Yuen,K; Phelan,M; Ratheesh,A; Schäfer,MR; Amminger,GP; Parker,AG; Piskulic,D; Harrigan,S; Mackinnon,AJ; Harrison,BJ; McGorry,PD
Data(s)

01/01/2014

Resumo

The aim of the Youth Depression Alleviation-Combined Treatment (YoDA-C) study is to determine whether antidepressant medication should be started as a first-line treatment for youth depression delivered concurrently with psychotherapy. Doubts about the use of medication have been raised by meta-analyses in which the efficacy and safety of antidepressants in young people have been questioned, and subsequent treatment guidelines for youth depression have provided only qualified support.

Identificador

http://hdl.handle.net/10536/DRO/DU:30069436

Idioma(s)

eng

Publicador

BioMed Central

Relação

http://dro.deakin.edu.au/eserv/DU:30069436/berk-additionoffluoxetine-2014.pdf

http://www.dx.doi.org/10.1186/1745-6215-15-425

http://www.ncbi.nlm.nih.gov/pubmed/25370185

Direitos

2014, BioMed Central

Palavras-Chave #Adolescence #Antidepressants #Cognitive behavioural therapy #Depression #Fluoxetine #Selective serotonin reuptake inhibitors #Youth #Science & Technology #Life Sciences & Biomedicine #Medicine, Research & Experimental #Research & Experimental Medicine #PLACEBO-CONTROLLED TRIAL #MAJOR DEPRESSION #DOUBLE-BLIND #ANTIDEPRESSANT TREATMENT #COMMUNITY SAMPLE #SELF-REPORT #ADOLESCENTS #DISORDER #CHILDREN #METAANALYSIS
Tipo

Journal Article